IK-930

· Ikena Oncology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IK-930, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors [Phase 1]